title: What Is the Appropriate Clinical Target Volume for Esophageal Squamous Cell Carcinoma? Debate and Consensus Based on Pathological and Clinical Outcomes.
abstract: Accurate delineation of clinical target volume (CTV) is critical in the effective management of squamous cell carcinoma (SCC) of esophagus using radiation therapy. Accurate delineation may improve the probability of local control and reduce the risk of complications. However, there are no consistent standards on the proper size of the margins added to the gross tumor volume (GTV). Different institutions and radiation oncologists have discordant opinions. In this paper, we review pathological and clinical outcomes to determine the most appropriate CTV for squamous cell carcinomas (SCC) of esophagus. The CTV for esophageal carcinoma should ensure that all subclinical lesions are encompassed regardless of the physical distance. The most precise method for delineating a reasonable CTV is to combine advanced imaging techniques, such as PET/CT and EUS, which allows the detection and prediction of subclinical lesions based on tumor characteristics such as the pathological type, differentiation, T disease, length and lymph node status.
authors.affiliation: 1. Department of Radiation Oncology, Shandong University Affiliated Shandong Cancer Hospital and Institute, Jinan, Shandong Province, China.; 3. Shandong Province Key Laboratory of Radiation Oncology, Jinan, Shandong Province, China.
authors.forename: Dali
authors.initials: D
authors.lastname: Han
authors.affiliation: 2. Department of Pathology, Shandong University Affiliated Shandong Cancer Hospital and Institute, Jinan, Shandong Province, China.; 3. Shandong Province Key Laboratory of Radiation Oncology, Jinan, Shandong Province, China.
authors.forename: Yinping
authors.initials: Y
authors.lastname: Yuan
authors.affiliation: 4. Department of Radiation Oncology, Jining Cancer Hospital, Jining, Shandong Province, China.
authors.forename: Xuqing
authors.initials: X
authors.lastname: Song
authors.affiliation: 1. Department of Radiation Oncology, Shandong University Affiliated Shandong Cancer Hospital and Institute, Jinan, Shandong Province, China.; 3. Shandong Province Key Laboratory of Radiation Oncology, Jinan, Shandong Province, China.
authors.forename: Yonghua
authors.initials: Y
authors.lastname: Yu
authors.affiliation: 1. Department of Radiation Oncology, Shandong University Affiliated Shandong Cancer Hospital and Institute, Jinan, Shandong Province, China.; 3. Shandong Province Key Laboratory of Radiation Oncology, Jinan, Shandong Province, China.
authors.forename: Jinming
authors.initials: J
authors.lastname: Yu
keywords: clinical target volume; esophageal squamous cell carcinoma; radiation therapy
references.citation: J Clin Oncol. 2005 Feb 1;23(4):874-9
references.pmid: 15681533
references.citation: Ann Surg. 1995 Aug;222(2):193-202
references.pmid: 7543742
references.citation: World J Surg. 1996 Jan;20(1):32-7
references.pmid: 8588409
references.citation: Surgery. 1999 Feb;125(2):142-7
references.pmid: 10026746
references.citation: Surg Today. 1998;28(9):873-8
references.pmid: 9744393
references.citation: Cancer. 1988 Apr 15;61(8):1635-8
references.pmid: 3349423
references.citation: Jpn J Clin Oncol. 2009 Feb;39(2):86-91
references.pmid: 19042946
references.citation: BMC Cancer. 2014 May 05;14:313
references.pmid: 24886020
references.citation: Cancer. 1990 Apr 15;65(8):1816-9
references.pmid: 2317758
references.citation: Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):818-23
references.pmid: 18718726
references.citation: Int J Cancer. 1995 May 4;61(3):333-6
references.pmid: 7729944
references.citation: JAMA. 1999 May 5;281(17):1623-7
references.pmid: 10235156
references.citation: Ann Surg Oncol. 2009 Feb;16(2):454-62
references.pmid: 19015923
references.citation: J Clin Oncol. 2001 Apr 1;19(7):1970-5
references.pmid: 11283129
references.citation: Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):389-96
references.pmid: 17236963
references.citation: Oncology (Williston Park). 2006 Apr;20(5):497-505; discussion 505-6, 511-3
references.pmid: 16739747
references.citation: Surgery. 2002 Jan;131(1 Suppl):S14-21
references.pmid: 11821782
references.citation: J Surg Oncol. 2005 Jan 1;89(1):6-11
references.pmid: 15612010
references.citation: Cancer Lett. 2015 Feb 1;357(1):69-74
references.pmid: 25464112
references.citation: J Surg Oncol. 2003 Aug;83(4):216-21
references.pmid: 12884233
references.citation: J Clin Oncol. 2002 Mar 1;20(5):1167-74
references.pmid: 11870157
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1235-41
references.pmid: 19910143
references.citation: Radiother Oncol. 2010 May;95(2):229-33
references.pmid: 20189259
references.citation: J Clin Pathol. 1996 Feb;49(2):124-9
references.pmid: 8655677
references.citation: Int J Cancer. 1992 Jan 2;50(1):49-52
references.pmid: 1728612
references.citation: J Surg Oncol. 1994 Sep;57(1):17-21
references.pmid: 8065145
references.citation: Langenbecks Arch Surg. 2004 Apr;389(2):122-7
references.pmid: 14997316
references.citation: Cancer. 1994 Dec 1;74(11):2889-95
references.pmid: 7954253
references.citation: Cancer. 2001 Oct 15;92(8):2228-33
references.pmid: 11596042
references.citation: Pathol Int. 2007 Dec;57(12):759-64
references.pmid: 17988276